Overview
Human-tissue-driven AI biotech for neurodegenerative diseases.
Details
Verge’s CONVERGE platform uses patient tissue genomics and ML to identify neurodegeneration targets. Lead ALS program in clinical trials.
Tags
drug-discovery, neurodegeneration, als, genomics, ml